| | 1622-62-4 Basic information More.. |
| Product Name: | FLUNITRAZEPAM | | Synonyms: | FLUNITRAZEPAM;5-[2-FLUOROPHENYL]-1-METHYL-7-NITRO-3H-1,4-BENZODIAZEPIN-2[1H]-ONE;RO 5-4200;1,3-dihydro-5-(2-fluorophenyl)-1-methyl-7-nitro-2h-4-benzodiazepin-2-one;1,3-Dihydro-5-(o-fluorophenyl)-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one;1-Methyl-7-nitro-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2(1H)-one;2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-(2-fluorophenyl)-1-methyl-7-nitro-;2H-1,4-Benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro- | | CAS: | 1622-62-4 | | MF: | C16H12FN3O3 | | MW: | 313.28 | | EINECS: | 216-597-8 | | Mol File: | 1622-62-4.mol |  |
Use
Flunitrazepam, a benzodiazepine derivative with sedative and
hypnotic activity, was introduced in 1974 for the management of anxiety. Although
it is subject to international control under Schedule IV of the 1971 Convention on
Psychotropic Substances, its potential for abuse by drug addicts has led at least
two countries (Germany and Turkey) to apply controls equivalent to those of Schedule II.
(Reference: (UNCPS4) United Nations Convention on Psychotropic Substances (IV),
, , 1971)
|
|
1622-62-4
Recommend
Suppliers |
|
|
Recommend You Select Member Companies |
|
1
|